✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

DiaSorin SpA

Common Name
DiaSorin
Country
Italy
Sector
Healthcare
Industry
Diagnostics & Research
Employees
3,212
Ticker
DIA
Exchange
EURONEXT MILAN
Description
DiaSorin S.p.A. is a global leader in the laboratory diagnostics market, specializing in immunodiagnostics and molecular diagnostics segments. Founded in 2000 and headquartered in Saluggia, Italy, the...

DiaSorin's Financial Statements Preview

Below are the financial statements of DiaSorin, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of EUR
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Non-current assets
Property, plant and equipment
271.36a
256.29a
Goodwill
846.86a
799.37a
Intangible assets
1,181.63a
1,125.61a
Equity investments
0.03a
0.03a
Deferred-tax assets
31.6a
31.81a
Other non-current assets
2.7a
2.76a
Other non-current financial assets
3.56a
12.89a
Total non-current assets
2,337.74a
2,228.75a
Current assets
Inventories
344.04a
315.5a
Trade receivables
194.7a
198.56a
Other current assets
35.18a
65.24a
Other current financial assets
49a
123.08a
Cash and cash equivalents
344.27a
280.31a
Total current assets
967.18a
982.69a
Total assets
3,304.92a
3,211.44a
Liabilities and shareholders’ equity
Shareholders’ equity
Share capital
55.95a
55.95a
Treasury shares
-251.78a
-296.8a
Additional paid-in capital
18.16a
18.16a
Statutory reserve
11.19a
11.19a
Other reserves and retained earnings
1,779.3a
1,590.27a
Net profit for the year
188.11a
159.85a
Total shareholders’ equity of the group
1,800.92a
1,538.61a
Minority interest in other reserves and retained earnings
-0.64a
0.76a
Minority interest in net result
-1.25a
-1.4a
Minority interest in shareholders’ equity
-1.9a
-0.64a
Total consolidated shareholders’ equity
1,799.02a
1,537.97a
Non-current liabilities
Non-current financial liabilities
966.78a
1,083.01a
Provisions for employee benefits
31.94a
32.31a
Deferred-tax liabilities
199.57a
199.6a
Provisions for risks and charges
22.73a
27.7a
Other non-current liabilities
9.58a
10.74a
Total non-current liabilities
1,230.6a
1,353.35a
Current liabilities
Trade payables
99.52a
100.71a
Other current liabilities
109.93a
100.36a
Current tax liabilities
18.07a
9.4a
Current financial liabilities
47.78a
109.65a
Total current liabilities
275.3a
320.12a
Total liabilities
1,505.9a
1,673.47a
Total shareholders’ equity and liabilities
3,304.92a
3,211.44a
Limited Data Preview
You are viewing a limited preview of DiaSorin’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind DiaSorin’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore DiaSorin’s data sources below and access millions more through our Disclosure Search.

a. DiaSorin's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?